| 1 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.19% |
| 2 | RNA | Avidity Biosciences, Inc. | 4.73% |
| 3 | NTRA | Natera, Inc. | 4.54% |
| 4 | ILMN | Illumina, Inc. | 4.40% |
| 5 | QGEN | Qiagen N.V. | 4.39% |
| 6 | GH | Guardant Health, Inc. | 4.32% |
| 7 | CRSP | CRISPR Therapeutics AG | 4.08% |
| 8 | RARE | Ultragenyx Pharmaceutical Inc. | 4.03% |
| 9 | MRNA | Moderna, Inc. | 4.01% |
| 10 | TECH | Bio-Techne Corporation | 3.93% |
| 11 | BNTX | BioNTech SE | 3.91% |
| 12 | LEGN | Legend Biotech Corporation | 3.74% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.67% |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 3.64% |
| 15 | VCYT | Veracyte, Inc. | 2.77% |
| 16 | SRPT | Sarepta Therapeutics, Inc. | 2.69% |
| 17 | HKG: 1548 | Genscript Biotech Corporation | 2.54% |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.50% |
| 19 | WGS | GeneDx Holdings Corp. | 2.29% |
| 20 | TWST | Twist Bioscience Corporation | 2.28% |
| 21 | A | Agilent Technologies, Inc. | 2.21% |
| 22 | LON: AZN | AstraZeneca PLC | 2.15% |
| 23 | GILD | Gilead Sciences, Inc. | 2.11% |
| 24 | BMY | Bristol-Myers Squibb Company | 2.01% |
| 25 | BEAM | Beam Therapeutics Inc. | 1.95% |
| View GNOM holdings |